Reuben SH. Living Beyond Cancer: Finding a New Balance. President’s Cancer Panel 2003–2004 Annual Report2004.

Schmitz KH, Cappola AR, Stricker CT, Sweeney C, Norman SA. The intersection of cancer and aging: establishing the need for breast cancer rehabilitation. Cancer Epidemiol Biomarkers Prev. 2007;16(5):866–72. https://doi.org/10.1158/1055-9965.EPI-06-0980.

Article  PubMed  Google Scholar 

Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20(1):76–89. https://doi.org/10.1080/138540491005875.

Article  PubMed  Google Scholar 

Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw. 2008;6(1):3–13. https://doi.org/10.6004/jnccn.2008.0002.

Article  PubMed  Google Scholar 

Pinto BM, Dunsiger S, Waldemore M. Physical activity and psychosocial benefits among breast cancer patients. Psychooncology. 2013;22(10):2193–9. https://doi.org/10.1002/pon.3272.

Article  PubMed  Google Scholar 

Hauth F, De-Colle C, Weidner N, Heinrich V, Zips D, Gani C. Quality of life and fatigue before and after radiotherapy in breast cancer patients. Strahlenther Onkol. 2021;197(4):281–7. https://doi.org/10.1007/s00066-020-01700-1.

Article  PubMed  Google Scholar 

Kim SY, Kissane DW, Richardson G, Senior J, Morgan J, Gregory P, et al. The role of depression and other psychological factors in work ability among breast cancer survivors in Australia. Psychooncology. 2022;31(2):167–75. https://doi.org/10.1002/pon.5802.

Article  PubMed  Google Scholar 

So SCY, Ng DWL, Liao Q, Fielding R, Soong I, Chan KKL, et al. Return to work and work productivity during the first year after cancer treatment. Front Psychol. 2022;13:866346. https://doi.org/10.3389/fpsyg.2022.866346.

Article  PubMed  PubMed Central  Google Scholar 

Kim HJ, Barsevick AM, Beck SL, Dudley W. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol Nurs Forum. 2012;39(1):E20-30. https://doi.org/10.1188/12.ONF.E20-E30.

Article  PubMed  Google Scholar 

Whisenant M, Wong B, Mitchell SA, Beck SL, Mooney K. Symptom trajectories are associated with co-occurring symptoms during chemotherapy for breast cancer. J Pain Symptom Manag. 2019;57(2):183–9. https://doi.org/10.1016/j.jpainsymman.2018.11.010.

Article  Google Scholar 

Trudel-Fitzgerald C, Savard J, Ivers H. Which symptoms come first? Exploration of temporal relationships between cancer-related symptoms over an 18-month period. Ann Behav Med. 2013;45(3):329–37. https://doi.org/10.1007/s12160-012-9459-1.

Article  PubMed  Google Scholar 

Trudel-Fitzgerald C, Savard J, Ivers H. Evolution of cancer-related symptoms over an 18-month period. J Pain Symptom Manag. 2013;45(6):1007–18. https://doi.org/10.1016/j.jpainsymman.2012.06.009.

Article  Google Scholar 

Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002;70(7):735–44. https://doi.org/10.1016/s0024-3205(01)01461-8.

Article  CAS  PubMed  Google Scholar 

Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223–50. https://doi.org/10.1007/978-3-642-45106-5_9.

Article  CAS  PubMed  Google Scholar 

Cappoli N, Tabolacci E, Aceto P, Dello Russo C. The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception. J Neuroimmunol. 2020;349:577406. https://doi.org/10.1016/j.jneuroim.2020.577406.

Article  CAS  PubMed  Google Scholar 

Castren E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021;90(2):128–36. https://doi.org/10.1016/j.biopsych.2021.05.008.

Article  CAS  PubMed  Google Scholar 

Saligan LN, Lukkahatai N, Holder G, Walitt B, Machado-Vieira R. Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy. World J Biol Psychiatry. 2016;17(8):608–14. https://doi.org/10.3109/15622975.2015.1012227.

Article  CAS  PubMed  Google Scholar 

Chang HA, Fang WH, Liu YP, Tzeng NS, Shyu JF, Wan FJ, et al. BDNF Val(6)(6)Met polymorphism to generalized anxiety disorder pathways: indirect effects via attenuated parasympathetic stress-relaxation reactivity. J Abnorm Psychol. 2020;129(3):237–47. https://doi.org/10.1037/abn0000507.

Article  PubMed  Google Scholar 

Andreatta M, Neueder D, Genheimer H, Schiele MA, Schartner C, Deckert J, et al. Human BDNF rs6265 polymorphism as a mediator for the generalization of contextual anxiety. J Neurosci Res. 2019;97(3):300–12. https://doi.org/10.1002/jnr.24345.

Article  CAS  PubMed  Google Scholar 

Erickson KI, Miller DL, Roecklein KA. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist. 2012;18(1):82–97. https://doi.org/10.1177/1073858410397054.

Article  CAS  PubMed  Google Scholar 

Homberg JR, Molteni R, Calabrese F, Riva MA. The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev. 2014;43:35–47. https://doi.org/10.1016/j.neubiorev.2014.03.012.

Article  CAS  PubMed  Google Scholar 

Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry. 2010;15(3):260–71. https://doi.org/10.1038/mp.2008.109.

Article  CAS  PubMed  Google Scholar 

Vossen H, Kenis G, Rutten B, van Os J, Hermens H, Lousberg R. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One. 2010;5(10):e13641. https://doi.org/10.1371/journal.pone.0013641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silveira Alves CF, Caumo W, Silvestri JM, Zortea M, Dos Santos VS, Cardoso DF, et al. Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia. Adv Rheumatol. 2020;60(1):39. https://doi.org/10.1186/s42358-020-00141-9.

Article  PubMed  Google Scholar 

Rovny R, Marko M, Michalko D, Mitka M, Cimrova B, Vancova Z, et al. BDNF Val66Met polymorphism is associated with consolidation of episodic memory during sleep. Biol Psychol. 2023;179:108568. https://doi.org/10.1016/j.biopsycho.2023.108568.

Article  PubMed  Google Scholar 

Feng LR, Juneau P, Regan JM, Liwang J, Alshawi S, Wang A, et al. Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue. Transl Psychiatry. 2020;10(1):302. https://doi.org/10.1038/s41398-020-00990-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolff BS, Allen HR, Feng LR, Saligan LN. BDNF Val66Met polymorphism reduces the fatigue-like effects of 5-fluorouracil on voluntary wheel-running activity in mice. Front Behav Neurosci. 2022;16:880969. https://doi.org/10.3389/fnbeh.2022.880969.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai JS, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011;92(10 Suppl):S20–7. https://doi.org/10.1016/j.apmr.2010.08.033.

Article  PubMed  PubMed Central  Google Scholar 

Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella DF, et al. Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): depression, anxiety, and anger. Assessment. 2011;18(3):263–83.

Article  PubMed  PubMed Central  Google Scholar 

Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, et al. Development of short forms from the PROMIS™ sleep disturbance and sleep-related impairment item banks. Behav Sleep Med. 2012;10(1):6–24.

Article